Galderma Group Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Flemming Ornskov
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3yrs |
| CEO ownership | 0.7% |
| Management average tenure | 2.8yrs |
| Board average tenure | 3yrs |
Recent management updates
No updates
CEO
Flemming Ornskov (66 yo)
3yrs
Tenure
Dr. Flemming Ornskov, M.D., MBA, MPH, serves as Chief Executive Officer at Galderma S.A. He is a Director and Chief Executive Officer of Galderma Group AG since 2022. He served as Member of the Supervisory...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3yrs | no data | 0.69% CHF 165.0m | |
| Chief Financial Officer | 5.3yrs | no data | 0.25% CHF 59.8m | |
| Head of Global Operations | 2.7yrs | no data | 0.0076% CHF 1.8m | |
| Head of Strategy | no data | no data | no data | |
| Chief Communications Officer | no data | no data | no data | |
| Chief Human Resources Officer | 2.6yrs | no data | 0.022% CHF 5.3m |
2.8yrs
Average Tenure
57yo
Average Age
Experienced Management: GALD's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3yrs | no data | 0.69% CHF 165.0m | |
| Independent Chairman | 3yrs | no data | 0.23% CHF 55.6m | |
| Director | 3yrs | no data | no data | |
| Independent Director | 3yrs | no data | 0.0075% CHF 1.8m | |
| Director | less than a year | no data | no data | |
| Independent Vice Chairman | 3yrs | no data | 0.011% CHF 2.6m | |
| Independent Director | 3yrs | no data | 0.0047% CHF 1.1m | |
| Director | 3yrs | no data | 0.0047% CHF 1.1m |
3.0yrs
Average Tenure
63yo
Average Age
Experienced Board: GALD's board of directors are considered experienced (3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 13:14 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Galderma Group AG is covered by 12 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bethan Davies | Berenberg |
| Richard Parkes | BNP Paribas Exane |
| Joffrey Meller | BofA Global Research |